Skip to main content
NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
7.40
-0.21 (-2.76%)
Apr 29, 2026, 1:14 PM EDT - Market open

NeurAxis Revenue

In the year 2025, NeurAxis had annual revenue of $3.57M with 32.89% growth. NeurAxis had revenue of $968.13K in the quarter ending December 31, 2025, with 27.19% growth.

Revenue (ttm)
$3.57M
Revenue Growth
+32.89%
P/S Ratio
24.30
Revenue / Employee
$148,720
Employees
24
Market Cap
85.14M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.57M883.36K32.89%
Dec 31, 20242.69M225.88K9.18%
Dec 31, 20232.46M-224.69K-8.37%
Dec 31, 20222.68M-36.55K-1.34%
Dec 31, 20212.72M791.06K40.98%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Champions Oncology 57.95M
Q32 Bio 53.74M
Sangamo Therapeutics 39.55M
Pelthos Therapeutics 16.80M
Rani Therapeutics Holdings 1.63M
Inovio Pharmaceuticals 65.34K
eXoZymes -700.00
Revenue Rankings

NRXS News

More News